ID

43752

Descripción

Collect Long-term Data on Subjects Following Participation in Previous EMD 531444 (L-BLP25 or BLP25 Liposome Vaccine) Clinical Trials; ODM derived from: https://clinicaltrials.gov/show/NCT01423760

Link

https://clinicaltrials.gov/show/NCT01423760

Palabras clave

  1. 6/3/16 6/3/16 -
  2. 20/9/21 20/9/21 -
Subido en

20 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Non-Small Cell Lung Cancer NCT01423760

Eligibility Non-Small Cell Lung Cancer NCT01423760

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
signed written informed consent.
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
registration and treatment in a clinical trial with tecemotide (l blp25) under sponsorship of merck kgaa / emd serono / merck serono japan (feeder trial). [note, subjects who have been allocated to treatments not containing tecemotide (l blp25) in the feeder trial are eligible for this trial and will be followed-up for pd (if applicable) and survival.]
Descripción

therapy tecemotide

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C3888078
end of treatment procedures have been performed in the feeder trial.
Descripción

therapy end

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0444930
additional inclusion criteria also apply.
Descripción

inclusion criteria

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1512693
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnancy and lactation period; women of childbearing potential, unless using effective contraception as determined by the investigator. subjects whom the investigator considers may be at risk of pregnancy will have a pregnancy test performed per institutional standard.
Descripción

pregnancy; lactating; Contraception status; pregnancy test

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0086287
UMLS CUI [4]
C0032976
known hypersensitivity to any of the trial treatment ingredients (if applicable).
Descripción

hypersensitivity study drugs

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0008972
legal incapacity or limited legal capacity.
Descripción

Functional capacity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1998319
any other reason that, in the opinion of the investigator, precludes the subject from participating in the trial.
Descripción

undefined item

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C0008972
additional exclusion criteria also apply.
Descripción

exclusion criteria

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251

Similar models

Eligibility Non-Small Cell Lung Cancer NCT01423760

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
informed consent
Item
signed written informed consent.
boolean
C0021430 (UMLS CUI [1])
therapy tecemotide
Item
registration and treatment in a clinical trial with tecemotide (l blp25) under sponsorship of merck kgaa / emd serono / merck serono japan (feeder trial). [note, subjects who have been allocated to treatments not containing tecemotide (l blp25) in the feeder trial are eligible for this trial and will be followed-up for pd (if applicable) and survival.]
boolean
C0087111 (UMLS CUI [1,1])
C3888078 (UMLS CUI [1,2])
therapy end
Item
end of treatment procedures have been performed in the feeder trial.
boolean
C0087111 (UMLS CUI [1,1])
C0444930 (UMLS CUI [1,2])
inclusion criteria
Item
additional inclusion criteria also apply.
boolean
C1512693 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pregnancy; lactating; Contraception status; pregnancy test
Item
pregnancy and lactation period; women of childbearing potential, unless using effective contraception as determined by the investigator. subjects whom the investigator considers may be at risk of pregnancy will have a pregnancy test performed per institutional standard.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0086287 (UMLS CUI [3])
C0032976 (UMLS CUI [4])
hypersensitivity study drugs
Item
known hypersensitivity to any of the trial treatment ingredients (if applicable).
boolean
C0020517 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
Functional capacity
Item
legal incapacity or limited legal capacity.
boolean
C1998319 (UMLS CUI [1])
undefined item
Item
any other reason that, in the opinion of the investigator, precludes the subject from participating in the trial.
boolean
C2828389 (UMLS CUI [1,1])
C0008972 (UMLS CUI [1,2])
exclusion criteria
Item
additional exclusion criteria also apply.
boolean
C0680251 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial